Accepting bidsitbPoland

Poland – Antineoplastic agents – Dostawa produktu leczniczego Pembrolizumab rozliczanego z programu lekowego B.6.

Poland – Antineoplastic agents – Delivery of Pembrolizumab cleared from the B.6. programmeEnglish, machine translated

Issued by Instytut Gruźlicy i Chorób Płuc · via TED — Tenders Electronic Daily (EU)

Published: 12 Nov 2026
Closes: 15 Dec 2026, 23:59 UTC
Reference: 789313-2026
Location: Poland
Sector: Healthcare & Pharma
Type: goods

At a glance

Instytut Gruźlicy i Chorób Płuc in Poland has published an invitation to bid in healthcare & pharma: “Poland – Antineoplastic agents – Dostawa produktu leczniczego Pembrolizumab rozliczanego z programu lekowego B.6.”. Submissions close on 15 December 2026, 34 days from today. Quote reference 789313-2026 in any correspondence with the buyer. One document is attached to this notice. FreeTender has recorded 20 notices from this buyer since 2026, 7 of them currently open. There are 1,072 open healthcare & pharma notices in Poland on FreeTender. Bids are submitted to the buyer through TED — Tenders Electronic Daily (EU), not through FreeTender.

Key requirements

Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.

To bid on EU public procurement

Most EU buyers ask for the European Single Procurement Document (ESPD) as a self-declaration with the bid. Submission is on the e-procurement platform named in the notice.

English summary

Machine translated from Polish by FreeTender. The original notice below is the binding text.

The subject of the order is the delivery of the medicinal product Pembrolizumab, concentrate for solution for infusion, 25mg/ ml; op x 1 vial. a 4 ml, Op. 4090. Lots Lot 1 — Delivery of the medicinal product Pembrolizumab accounted for from the B.6. programme: Delivery of the product Pembrolizumab, concentrate for solution for infusion, 25mg/ ml is the subject of the order; op x 1 vial. a 4 ml op.

Details

Przedmiotem zamówienia jest dostawa produktu leczniczego Pembrolizumab, koncentrat do sporządzania roztworu do infuzji, 25mg/ ml; op x 1 fiol. a 4 ml, op. 4090.

Lots Lot 1 — Dostawa produktu leczniczego Pembrolizumab rozliczanego z programu lekowego B.6.: Przedmiotem zamówienia jest dostawa produktu leczniczego Pembrolizumab, koncentrat do sporządzania roztworu do infuzji, 25mg/ ml; op x 1 fiol. a 4 ml, op. 4090

Buyer: Instytut Gruźlicy i Chorób Płuc

Buyer country: POL

Procedure: open

CPV code: 33652100

Full notice, tender documents and how to bid are on the official TED page (link above).

Context for bidders

We hold 20 notices from Instytut Gruźlicy i Chorób Płuc, going back to August 2026 — 7 of them still open. There are 1,072 open Healthcare & Pharma tenders in Poland. This one closes in 34 days.

Similar Healthcare & Pharma tenders

Documents

TED-official-notice-789313-2026.pdfDownload (pdf)

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.

Common bidding mistakes to avoid →Writing a winning proposal